companydata.dkcompanydata.dk

GSK 2023 ApS: Financial statements 2015

CVR: 43456415

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

GSK 2023 ApS (CVR 43456415) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 2,780,011 and a net result of DKK 5,346,193 compared with DKK 5,673,521 the year before. That is a decrease of 2.7% compared with the year before. Equity in the 2015 report amounted to DKK 52,301,248. The solvency ratio was 80%.

Gross Profit
DKK 2,780,011
Profit/Loss
DKK 5,346,193
Equity
DKK 52,301,248
Total Assets
DKK 65,412,446

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-2.8 mio.5.3 mio.52.3 mio.-
2014-2.9 mio.5.7 mio.47.2 mio.-
2013-2.9 mio.3.8 mio.44.8 mio.-
2012-3.1 mio.3.9 mio.40.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is GSK 2023 ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

GSK 2023 ApS: The 2014 annual report is outMay 27, 2015

GSK 2023 ApS has published its annual report for 2014. Gross profit came to DKK 2,857,630, and the net result was DKK 5,673,521.

About GSK 2023 ApS

GSK 2023 ApS is a Danish company of the type Anpartsselskab based in Sæby, founded in 1972. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named B6 HOLDING A/S and B 6 AF 1972 A/S. The management consists of Brian Stenbro. The board consists of Kurt Valdemar Stenbro (chair), Brian Stenbro and Malene Stenbro. The company is owned by M.A.S.T. Holding ApS, BriSt Holding 2023 ApS and KVS Holding, Sæby ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -30,332 and a net result of DKK -5,937 compared with DKK 372,677 the year before. Equity in the 2025 report amounted to DKK 4,181,703.

Source: annual report 2025, Danish Business Authority